Startup Funding News
Explore funding rounds, the companies behind them and the investors taking part.
- Rounds
- 4,817 All time
- Disclosed funding
- $368.6B 3764 disclosed amounts
- Median round
- $14.7M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SB Shennon BiotechnologiesCompany profile Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors. Shennon Biotechnologies is developing precision T-cell engager immunotherapies for solid tumors. | $12M | FundingUndisclosed | Biotech | United States | Investors | |
Circuits Integrated HellasCompany profile Circuits Integrated Hellas develops integrated radio-frequency semiconductor modules for satellite communications, combining power amplification and switching to make satcom equipment more compact and cost-efficient. Circuits Integrated Hellas develops integrated radio-frequency semiconductor modules for satellite communications, combining power amplification and switching to make satcom equipment more compact and cost-efficient. | Undisclosed | Pre-SeedPre-seed | Hardware | Greece | Investors | |
| NH Nara HealthCompany profile Nara Health administers employer health plans through an AI-enabled platform for benefits, claims, care coordination and member support. Nara Health administers employer health plans through an AI-enabled platform for benefits, claims, care coordination and member support. | Undisclosed | Seed | Healthtech | United States | Investors | |
ResolutiionCompany profile AI software that helps enterprise teams spot delivery friction and resolve commercial contract problems before they become formal disputes. AI software that helps enterprise teams spot delivery friction and resolve commercial contract problems before they become formal disputes. | $10.4M | Funding roundUndisclosed | Enterprise software | United Kingdom | Investors | |
| AB Athernal BioCompany profile Targeted immunotherapies aim to stop blood cancers by treating high-risk clonal hematopoiesis before malignancy emerges. Targeted immunotherapies aim to stop blood cancers by treating high-risk clonal hematopoiesis before malignancy emerges. | ~£700K | GrantUndisclosed | Biotech | United Kingdom | Investors | |
Cornelis NetworksCompany profile High-speed network fabrics that connect GPUs and CPUs in AI and high-performance computing clusters, helping keep accelerators productive as workloads exchange data. High-speed network fabrics that connect GPUs and CPUs in AI and high-performance computing clusters, helping keep accelerators productive as workloads exchange data. | ~$205M | Funding roundUndisclosed | AI | United States | Investors | |
| EC Everywhere CommunicationsCompany profile A connected field-safety platform keeps distributed teams reachable and helps supervisors coordinate people in remote, high-risk settings. A connected field-safety platform keeps distributed teams reachable and helps supervisors coordinate people in remote, high-risk settings. | Undisclosed | InvestmentUndisclosed | Business services | United States | Investors | |
AniwaCompany profile Aniwa is a digital insurance assistant that organizes personal policies, compares coverage and sends alerts before renewals. Aniwa is a digital insurance assistant that organizes personal policies, compares coverage and sends alerts before renewals. | >€500K | Funding roundUndisclosed | Fintech | Spain | Investors Undisclosed | |
| VH Vheda HealthCompany profile A care-management program combines analytics, connected devices and live support to help health plans engage high-risk members. A care-management program combines analytics, connected devices and live support to help health plans engage high-risk members. | $47M | InvestmentUndisclosed | Healthtech | United States | Investors | |
| P PistonCompany profile A cardless fuel-payment network connects commercial fleets and stations with real-time controls for every fill. A cardless fuel-payment network connects commercial fleets and stations with real-time controls for every fill. | $15M | Series A | Fintech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
BioStack, Tractian, Blacksmith
162rounds5led - 2Andreessen Horowitz (a16z)
ASI, Eka Robotics, Town
115rounds22led - 3General Catalyst
Provision Labs, Tractian, Legora
104rounds14led - 4Lightspeed
Warp Sciences, Different, Zenzap
82rounds9led - 5Sequoia Capital
Warhound, Whop, Blacksmith
71rounds13led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.
Browse rounds by topic
Geography
Featured selections
Nordic Foodtech Fund II pairs early capital with scientific expertise
An EIF pledge of up to €30m supports a fund targeting €80m for science-led agrifood companies.
Read the research →